Retinal ischemic injury rescued by sodium 4-phenylbutyrate in a rat model

Experimental Eye Research

Volumn 84, Issue 3, 2007, Pages 486-492

  Jeng, Yung Yue ^a   Lin, Nien Ting ^a   Chang, Pen Heng ^a   Huang, Yuan Ping ^a   Pang, Victor Fei ^a   Liu, Chen Hsuan ^a   Lin, Chung Tien ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

ischemia; PBA; rat; retina; sodium 4 phenylbutyrate

Indexed keywords

4 PHENYLBUTYRIC ACID; FLUOROGOLD;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LABELING; CELL LOSS; CELL SURVIVAL; CONTROLLED STUDY; DISEASE MODEL; INTRAOCULAR PRESSURE; MALE; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA GANGLION CELL; RETINA ISCHEMIA;

ANIMALS; CELL COUNT; CELL DEATH; DOSE-RESPONSE RELATIONSHIP, DRUG; GLAUCOMA; ISCHEMIA; MALE; MICROSCOPY, FLUORESCENCE; MODELS, ANIMAL; PHENYLBUTYRATES; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; RETINAL DISEASES; RETINAL GANGLION CELLS; RETINAL VESSELS;

EID: 33846834078     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2006.11.001     Document Type: Article

References (33)

1. Adachi K., Fujita Y., Morizane C., Akaike A., Ueda M., Satoh M., Masai H., Kashii S., and Honda Y. Inhibition of NMDA receptors and nitric oxide synthase reduces ischemic injury of the retina. Eur. J. Pharmacol. 350 (1998) 53-57
2. Andreassi C., Angelozzi C., Tiziano F.D., Vitali T., De Vincenzi E., Boninsegna A., Villanova M., Bertini E., Pini A., Neri G., and Brahe C. Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy. Eur. J. Hum. Genet. 12 (2004) 59-65
3. Aviles-Trigueros M., Mayor-Torroglosa S., Garcia-Aviles A., Lafuente M.P., Rodriguez M.E., Miralles de Imperial J., Villegas-Perez M.P., and Vidal-Sanz M. Transient ischemia of the retina results in massive degeneration of the retinotectal projection: long-term neuroprotection with brimonidine. Exp. Neurol. 184 (2003) 767-777
4. Batshaw M.L., MacArthur R.B., and Tuchman M. Alternative pathway therapy for urea cycle disorders: twenty years later. J. Pediatr. 138 (2001) 46-54
5. Berg S., Serabe B., Aleksic A., Bomgaars L., McGuffey L., Dauser R., Durfee J., Nuchtern J., and Blaney S. Pharmacokinetics and cerebrospinal fluid penetration of phenylacetate and phenylbutyrate in the nonhuman primate. Cancer Chemother. Pharmacol. 47 (2001) 385-390
6. Burrows J.A., Willis L.K., and Perlmutter D.H. Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: a potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 1796-1801
7. Carducci M.A., Gilbert J., Bowling M.K., Noe D., Eisenberger M.A., Sinibaldi V., Zabelina Y., Chen T.L., Grochow L.B., and Donehower R.C. A phase I clinical and pharmacological evaluation of sodium phenylbutyrate on an 120-h infusion schedule. Clin. Cancer Res. 7 (2001) 3047-3055
8. Collins A.F., Pearson H.A., Giardina P., McDonagh K.T., Brusilow S.W., and Dover G.J. Oral sodium phenylbutyrate therapy in homozygous beta thalassemia: a clinical trial. Blood 85 (1995) 43-49
9. Danias J., Shen F., Goldblum D., Chen B., Ramos-Esteban J., Podos S.M., and Mittag T. Cytoarchitecture of the retinal ganglion cells in the rat. Investig. Ophthalmol. Vis. Sci. 43 (2002) 587-594
10. Dasgupta S., Zhou Y., Jana M., Banik N.L., and Pahan K. Sodium phenylacetate inhibits adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice at multiple steps. J. Immunol. 170 (2003) 3874-3882
11. Dover G.J., Brusilow S., and Charache S. Induction of fetal hemoglobin production in subjects with sickle cell anemia by oral sodium phenylbutyrate. Blood 84 (1994) 339-343
12. Dreher B., Sefton A.J., Ni S.Y., and Nisbett G. The morphology, number, distribution and central projections of Class I retinal ganglion cells in albino and hooded rats. Brain Behav. Evol. 26 (1985) 10-48
13. Farid Ahmed A.K., Dong K., Hanna G.F., and Yamadori T. Retrograde double-labeling study of retinal ganglion cells from the ipsilateral vLGN and SC in the albino rat. Neurosci. Lett. 244 (1998) 47-51
14. Gardian G., Browne S.E., Choi D.K., Klivenyi P., Gregorio J., Kubilus J.K., Ryu H., Langley B., Ratan R.R., Ferrante R.J., and Beal M.F. Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease. J. Biol. Chem. 280 (2005) 556-563
15. Gehlbach P.L., and Purple R.L. A paired comparison of two models of experimental retinal ischemia. Curr. Eye Res. 13 (1994) 597-602
16. Geyer O., Almog J., Lupu-Meiri M., Lazar M., and Oron Y. Nitric oxide synthase inhibitors protect rat retina against ischemic injury. FEBS Lett. 374 (1995) 399-402
17. Gross R.L., Hensley S.H., Gao F., and Wu S.M. Retinal ganglion cell dysfunction induced by hypoxia and glutamate: potential neuroprotective effects of beta-blockers. Surv. Ophthalmol. 43 (1999) 162-170
18. King A.J. The superior colliculus. Curr. Biol. 14 (2004) 335-338
19. Lafuente M.P., Villegas-Perez M.P., Sobrado-Calvo P., Garcia-Aviles A., Miralles de Imperial J., and Vidal-Sanz M. Neuroprotective effects of a2-selective adrenergic agonists against ischemia-induced retinal ganglion cell death. Invest. Ophthalmol. Vis. Sci. 42 (2001) 2074-2084
20. Lagreze W.A., Knorle R., Bach M., and Feuerstein T.J. Memantine is neuroprotective in a rat model of pressure-induced retinal ischemia. Investig. Ophthalmol. Vis. Sci. 39 (1998) 1063-1066
21. Maestri N.E., Brusilow S.W., Clissold D.B., and Bassett S.S. Long-term treatment of girls with ornithine transcarbamylase deficiency. N. Engl. J. Med. 335 (1996) 855-859
22. Mercuri E., Bertini E., Messina S., Pelliccioni M., D'Amico A., Colitto F., Mirabella M., Tiziano F.D., Vitali T., Angelozzi C., Kinali M., Main M., and Brahe C. Pilot trial of phenylbutyrate in spinal muscular atrophy. Neuromuscul. Disord. 14 (2004) 130-135
23. Neufeld A.H., Das S., Vora S., Gachie E., Kawai S., Manning P.T., and Connor J.R. A prodrug of a selective inhibitor of inducible nitric oxide synthase is neuroprotective in the rat model of glaucoma. J. Glaucoma 11 (2002) 221-225
24. Osborne N.N., Casson R.J., Wood J.P., Chidlow G., Graham M., and Melena J. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog. Retin. Eye Res. 23 (2004) 91-147
25. Osborne N.N., Ugarte M., Chao M., Chidlow G., Bae J.H., Wood J.P., and Nash M.S. Neuroprotection in relation to retinal ischemia and relevance to glaucoma. Surv. Ophthalmol. 43 (1999) 102-128
26. Perlmutter D.H. Chemical chaperones: a pharmacological strategy for disorders of protein folding and trafficking. Pediatr. Res. 52 (2002) 832-836
27. Qi X., Hosoi T., Okuma Y., Kaneko M., and Nomura Y. Sodium 4-phenylbutyrate protects against cerebral ischemic injury. Mol. Pharmacol. 66 (2004) 899-908
28. Rubenstein R.C., and Zeitlin P.L. Sodium 4-phenylbutyrate downregulates Hsc70: implications for intracellular trafficking of DeltaF508-CFTR. Am. J. Physiol. Cell Physiol. 278 (2000) 259-267
29. Ryu H., Smith K., Camelo S.I., Carreras I., Lee J., Iglesias A.H., Dangond F., Cormier K.A., Cudkowicz M.E., Brown Jr. R.H., and Ferrante R.J. Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice. J. Neurochem. 93 (2005) 1087-1098
30. Selles-Navarro I., Villegas-Perez M.P., Salvador-Silva M., Ruiz-Gomez J.M., and Vidal-Sanz M. Retinal ganglion cell death after different transient periods of pressure-induced ischemia and survival intervals. A quantitative in vivo study. Invest. Ophthalmol. Vis. Sci. 37 (1996) 2002-2014
31. Smith G.G., and Baird C.D. Survival time of retinal cells when deprived of their blood supply by increased intraocular pressure. Am. J. Ophthalmol. 35 (1952) 133-136
32. Stieg P.E., Sathi S., Warach S., Le D.A., and Lipton S.A. Neuroprotection by the NMDA receptor-associated open-channel blocker memantine in a photothrombotic model of cerebral focal ischemia in neonatal rat. Eur. J. Pharmacol. 375 (1999) 115-120
33. Teckman J.H. Lack of effect of oral 4-phenylbutyrate on serum alpha-1-antitrypsin in patients with alpha-1-antitrypsin deficiency: a preliminary study. J. Pediatr. Gastroenterol. Nutr. 39 (2004) 34-37